116 related articles for article (PubMed ID: 37054577)
1. C6orf15 acts as a potential novel marker of adverse pathological features and prognosis for colon cancer.
Xiong X; Wang S; Gao Z; Ye Y
Pathol Res Pract; 2023 May; 245():154426. PubMed ID: 37054577
[TBL] [Abstract][Full Text] [Related]
2. C6orf15 promotes liver metastasis via WNT/β-catenin signalling in colorectal cancer.
Yu J; Sun J; Tang J; Xu J; Qian G; Zhou J
Cancer Cell Int; 2024 Apr; 24(1):146. PubMed ID: 38654238
[TBL] [Abstract][Full Text] [Related]
3. Retinoblastoma binding protein 4 up-regulation is correlated with hepatic metastasis and poor prognosis in colon cancer patients.
Li YD; Lv Z; Xie HY; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):446-451. PubMed ID: 31501018
[TBL] [Abstract][Full Text] [Related]
4. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
5. High expression of PLAC1 in colon cancer as a predictor of poor prognosis: A study based on TCGA data.
Ren Y; Lv Y; Li T; Jiang Q
Gene; 2020 Dec; 763():145072. PubMed ID: 32827679
[TBL] [Abstract][Full Text] [Related]
6. Expression of smoothened protein in colon cancer and its prognostic value for postoperative liver metastasis.
Ding YL; Wang QS; Zhao WM; Xiang L
Asian Pac J Cancer Prev; 2012; 13(8):4001-5. PubMed ID: 23098507
[TBL] [Abstract][Full Text] [Related]
7. [Expression of transcriptional coactivator with PDZ-binding motif (TAZ) in colon cancer tissues and its clinical significance].
Zeng C; Huang L; Zheng Y; Huang H; Chen L; Chi L
Zhonghua Wei Chang Wai Ke Za Zhi; 2015 Nov; 18(11):1154-7. PubMed ID: 26616814
[TBL] [Abstract][Full Text] [Related]
8. TIMP1 is a prognostic marker for the progression and metastasis of colon cancer through FAK-PI3K/AKT and MAPK pathway.
Song G; Xu S; Zhang H; Wang Y; Xiao C; Jiang T; Wu L; Zhang T; Sun X; Zhong L; Zhou C; Wang Z; Peng Z; Chen J; Wang X
J Exp Clin Cancer Res; 2016 Sep; 35(1):148. PubMed ID: 27644693
[TBL] [Abstract][Full Text] [Related]
9. Low expression of bestrophin-2 is associated with poor prognosis in colon cancer.
Wang L; Zhu H; Sun W; Liang L; Li H; Han C; Huang W; Zhao B; Peng P; Qin M; Shi L; Mo Y; Huang J
Gene; 2022 Mar; 813():146117. PubMed ID: 34902511
[TBL] [Abstract][Full Text] [Related]
10. Tumor Suppressive Role of ARHGAP17 in Colon Cancer Through Wnt/β-Catenin Signaling.
Pan S; Deng Y; Fu J; Zhang Y; Zhang Z; Ru X; Qin X
Cell Physiol Biochem; 2018; 46(5):2138-2148. PubMed ID: 29730655
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of MVD, LVD and vascular invasion in lymph node-negative colon cancer.
Sundov Z; Tomic S; Alfirevic S; Sundov A; Capkun V; Nincevic Z; Nincevic J; Kunac N; Kontic M; Poljak N; Druzijanic N
Hepatogastroenterology; 2013 May; 60(123):432-8. PubMed ID: 23321007
[TBL] [Abstract][Full Text] [Related]
12. High NUSAP1 expression predicts poor prognosis in colon cancer.
Liu Z; Guan C; Lu C; Liu Y; Ni R; Xiao M; Bian Z
Pathol Res Pract; 2018 Jul; 214(7):968-973. PubMed ID: 29853313
[TBL] [Abstract][Full Text] [Related]
13. Positive expression of LSD1 and negative expression of E-cadherin correlate with metastasis and poor prognosis of colon cancer.
Jie D; Zhongmin Z; Guoqing L; Sheng L; Yi Z; Jing W; Liang Z
Dig Dis Sci; 2013 Jun; 58(6):1581-9. PubMed ID: 23314859
[TBL] [Abstract][Full Text] [Related]
14. [Comparison of clinicopathological features and prognosis between left-sided colon cancer and right-sided colon cancer].
Gao X; Yu G; Liu P; Hao L; Liu L; Zhang W
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Jun; 20(6):647-653. PubMed ID: 28643309
[TBL] [Abstract][Full Text] [Related]
15. Msi-1 is a predictor of survival and a novel therapeutic target in colon cancer.
Li D; Peng X; Yan D; Tang H; Huang F; Yang Y; Peng Z
Ann Surg Oncol; 2011 Jul; 18(7):2074-83. PubMed ID: 21442350
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of hedgehog signaling pathway in patients with colon cancer.
Xu M; Li X; Liu T; Leng A; Zhang G
Med Oncol; 2012 Jun; 29(2):1010-6. PubMed ID: 21424326
[TBL] [Abstract][Full Text] [Related]
17. ARL9 is upregulated and serves as a biomarker for a poor prognosis in colon adenocarcinoma.
Yang HD; Jin XX; Gu BB; Yu-Zhang ; Li D; Yan LL
BMC Gastroenterol; 2023 Feb; 23(1):48. PubMed ID: 36823542
[TBL] [Abstract][Full Text] [Related]
18. Increased Kremen2 predicts worse prognosis in colon cancer.
Long J; Cong F; Wei Y; Liu J; Tang W
Pathol Oncol Res; 2023; 29():1611082. PubMed ID: 37123533
[No Abstract] [Full Text] [Related]
19. Correlations of insulin-like growth factor I and insulin-like growth factor I receptor with the clinicopathological features and prognosis of patients with colon cancer.
Han L; Zhang GF; Cheng YH; Zhao QC
Jpn J Clin Oncol; 2016 Dec; 46(12):1127-1134. PubMed ID: 27737962
[TBL] [Abstract][Full Text] [Related]
20. Prognostic impact of mitofusin 2 expression in colon cancer.
Cheng X; Li Y; Liu F
Transl Cancer Res; 2022 Oct; 11(10):3610-3619. PubMed ID: 36388028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
